Ocugen Earnings Call: Key Takeaways
Ocugen is transitioning to a late-stage clinical company with three Phase 3 programs, targeting BLA filings by 2028 and leveraging international licensing for non-dilutive capital.
- Call
- Nov 4, 2026, 8:30 AM ET
ALFA USA Filings
Every alert, straight from SEC EDGAR
Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Filing type
Alerts
Time
21,430 alerts with these filters
Ocugen is transitioning to a late-stage clinical company with three Phase 3 programs, targeting BLA filings by 2028 and leveraging international licensing for non-dilutive capital.
William Edward Mitchell, Director, bought 1,300 shares of Umh Properties, Inc. at $15.06 a share, worth $19.6K in total on Nov 4, 2026. Shares held after the trade: 38,682 (+3.5%).
David W. Grzebinski, CEO, sold 18,310 shares of Kirby Corp at $141.32 a share, worth $2.59M in total on Nov 2, 2026. Shares held after the trade: 79,931 (-18.6%).
Lynda Scearcy sold 8,010 shares of Sierra Bancorp at $42.15 a share, worth $338K in total on Nov 3, 2026. Shares held after the trade: 16,273 (-33.0%).
OPENLANE delivered strong 13% revenue growth and 23% EBITDA growth, driven by US commercial volume and dealer-to-dealer momentum, despite macroeconomic headwinds in Canada and declining used vehicle values.
CDW delivered a strong Q3 beat driven by AI-related infrastructure demand, raising full-year EPS guidance while demonstrating significant operating leverage through its 'Geared for Growth' efficiency program.
AEP Transmission Company, LLC entered into an underwriting agreement to issue and sell $550 million of its 6.20% Senior Notes, Series T, due 2056. The offering is led by BMO Capital Markets, BNY Mellon, Santander, and Truist Securities as representatives of the underwriters.
Omega Healthcare Investors reported a significant increase in total revenues to $991.8 million for the nine months ended September 30, 2026, compared to $870.9 million in the prior year. Net income available to common stockholders rose to $597.0 million, driven largely by a $249.1 million gain on assets sold.
The Andersons, Inc. reported a significant increase in net income for the nine months ended September 30, 2026, reaching $136.2 million compared to $28.3 million in the prior year. This growth was driven by improved gross profits and higher other income, despite an increase in interest expenses and operating costs.
Caterpillar Financial Services Corp reported total revenues of $1,021 million for the third quarter of 2026, up from $926 million in 2025, driven by growth in retail and wholesale finance. Net profit attributable to the corporation rose to $145 million for the quarter, while total assets increased to $41.36 billion as of September 30, 2026.
Avient Corporation reported a significant increase in net income for the nine months ended September 30, 2026, reaching $165.0 million compared to $66.4 million in the prior year period. Sales grew to $2,655.6 million, and operating income rose to $290.8 million, driven by higher gross margins and lower selling and administrative expenses relative to the previous year.
Enterprise Products Partners L.P. reported a significant increase in total revenues to $50.6 billion for the nine months ended September 30, 2026, compared to $38.8 billion in the prior year. Net income attributable to common unitholders rose to $4.95 billion, driven by higher operating income, while the partnership continued its capital return strategy through $3.6 billion in cash distributions and $387 million in unit repurchases.
Caterpillar Inc. reported its Q3 2026 results, highlighting performance across its Machinery, Energy & Transportation, and Financial Products segments. The filing includes detailed reconciliations of segment profit and consolidated assets, as well as updates on derivative hedging activities and intangible asset amortization.
Marita Zuraitis, President & CEO, sold 7,500 shares of Horace Mann Educators Corp at $47.20 a share, worth $354K in total on Nov 2, 2026. Shares held after the trade: 286,384 (-2.6%).
CRH plc's subsidiary CRH America Finance, Inc. has launched cash tender offers and exchange offers for up to $1 billion of senior notes originally issued by Arcosa, Inc. The transaction follows CRH's acquisition of Arcosa on October 23, 2026, and aims to replace Arcosa's existing debt with new notes guaranteed by CRH plc.
Aircastle Limited announced it will cease voluntarily filing periodic reports with the SEC, with its August 31, 2026 Form 10-Q expected to be its final filing. The company, which became privately held in 2020, will transition to providing audited annual and unaudited quarterly GAAP financial statements directly through its website. The move follows the repayment of bonds that previously required SEC reporting under their indentures.
Marriott Vacations Worldwide reported total revenues of $1.37 billion for the third quarter of 2026, up from $1.26 billion in the prior year, driven by growth in vacation ownership product sales. Net income attributable to common stockholders improved significantly to $82 million ($2.24 per diluted share) compared to a net loss of $2 million in the same period of 2025.
Array Technologies entered into a definitive agreement to acquire Shoals Technologies Group in an all-stock merger, creating an integrated solar energy infrastructure platform. Shoals shareholders will receive 1.6931 shares of Array common stock for each Shoals share, resulting in Shoals shareholders owning approximately 65% of the combined company. The transaction is expected to generate over $100 million in annual Adjusted EBITDA synergies within three years.
Christopher D. Cook bought 1,500 shares of Richmond Mutual Bancorporation, Inc. at $15.54 a share, worth $23.3K in total on Nov 4, 2026. Shares held after the trade: 27,686 (+5.7%).
CS Disco achieved 15% revenue growth and reached adjusted EBITDA profitability early, driven by strong adoption of its AI-native platform and large customer expansion.
Enova International announced a private offering of $600 million in senior notes due 2031 to qualified institutional buyers. The company intends to use the proceeds to redeem all $400 million of its outstanding 11.25% senior notes due 2028 and repay a portion of its revolving credit facility.
Bradley J. Dodson, President & CEO, sold 23,288 shares of Civeo Corp at $37.17 a share, worth $866K in total on Nov 2, 2026. Shares held after the trade: 238,178 (-8.9%).
SelectQuote outperformed EBITDA and cash flow expectations despite a 15% revenue decline, pivoting to a profitability-first strategy through AI-driven efficiency and healthcare services margin expansion.
Acushnet delivered a solid Q3 with strong club and ball performance, though Q4 guidance implies a seasonal loss due to product launch timing and tariff normalization.
Amir Schlachet, CEO, sold 24,999 shares of Global-E Online Ltd. at $40.97 to $41.48 a share (average $41.39) in 2 transactions, worth $1.03M in total on Nov 3, 2026. Shares held after the trade: 3,616,736 (-0.6%).
OPENLANE, Inc. reported total operating revenues of $1,643.7 million for the nine months ended September 30, 2026, a significant increase from $1,440.2 million in the prior year. Net income for the same period rose to $137.9 million, driven by growth in auction fees and finance revenue, despite higher operating expenses and interest costs.
Nir Debbi, President, sold 14,582 shares of Global-E Online Ltd. at $42.31 to $43.80 a share (average $43.22) in 3 transactions, worth $630K in total on Nov 2, 2026. Shares held after the trade: 4,342,793 (-0.0%).
City Holding Company reported net income of $99.6 million for the first nine months of 2026, a slight increase from $98.9 million in the prior year period. While net interest income grew to $183.0 million, the company experienced a significant increase in accumulated other comprehensive loss due to $72.1 million in unrealized losses on available-for-sale securities.
Seres Therapeutics is a clinical-stage company that has identified conditions raising substantial doubt about its ability to continue as a going concern. The company reported 10,195,031 shares of common stock outstanding as of November 2, 2026, and is seeking additional funding or strategic partnerships to advance its SER-155 clinical programs.
Viridian Therapeutics reported a strong LUMVO launch with $24.7 million in revenue, treating over 100 patients in its first quarter, while maintaining a robust $955 million cash position for future pipeline development.